Butler D
J Comp Physiol B. 2007; 177(7):733-42.
PMID: 17576569
DOI: 10.1007/s00360-007-0170-7.
Butler D, Lam W, Tong J
J Comp Physiol B. 2005; 176(1):35-43.
PMID: 16292650
DOI: 10.1007/s00360-005-0029-8.
von Bibra H, Gibson D, Nityanandan K
Br Heart J. 1980; 43(3):293-300.
PMID: 7437176
PMC: 482278.
DOI: 10.1136/hrt.43.3.293.
Dehmer G, Falkoff M, Lewis S, Hillis L, Parkey R, Willerson J
Br Heart J. 1981; 45(6):656-66.
PMID: 7259915
PMC: 482579.
DOI: 10.1136/hrt.45.6.656.
Forfar J, Muir A, Toft A
Br Heart J. 1982; 48(3):278-84.
PMID: 7104121
PMC: 481242.
DOI: 10.1136/hrt.48.3.278.
Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
Condorelli M, Brevetti G, Chiariello M, Miceli D, LaVecchia G, Paudice G
Br J Clin Pharmacol. 1982; 13(1 Suppl):101S-110S.
PMID: 7093092
PMC: 1401826.
DOI: 10.1111/j.1365-2125.1982.tb01897.x.
Right ventricular performance in essential hypertension after beta-blockade.
Ferlinz J, Easthope J, Hughes D, Siegel J, Tobis J, Aronow W
Br Heart J. 1981; 46(1):23-9.
PMID: 7023516
PMC: 482597.
DOI: 10.1136/hrt.46.1.23.
High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences.
Zito R, Cassell I, Cunningham M, Gradman A, Ross A, Zaret B
Yale J Biol Med. 1980; 53(3):173-9.
PMID: 6250292
PMC: 2595884.
Videometry studies of left ventricular wall movement after myocardial infarction.
Sutherland G, Evans A, Davison M, Kennedy J
Br Heart J. 1973; 35(7):705-13.
PMID: 4718822
PMC: 458687.
DOI: 10.1136/hrt.35.7.705.
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Gibson D
Drugs. 1974; 7(1):8-38.
PMID: 4151693
DOI: 10.2165/00003495-197407010-00002.
Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
Ades P, Wolfel E, Hiatt W, Fee C, Rolfs R, Brammell H
Eur J Clin Pharmacol. 1989; 36(1):5-10.
PMID: 2917588
DOI: 10.1007/BF00561015.
Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity have any influence during chronic therapy?.
Northcote R, Cooke M, Ballantyne D
Cardiovasc Drugs Ther. 1988; 2(4):549-60.
PMID: 2908709
DOI: 10.1007/BF00051195.
Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
Cambridge D, Whiting M, Allan G
Br J Pharmacol. 1988; 93(1):165-75.
PMID: 2894874
PMC: 1853785.
DOI: 10.1111/j.1476-5381.1988.tb11418.x.
Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: relationship of pharmacokinetics and pharmacodynamics.
Corbo M, Wang P, Li J, Chien Y
J Pharmacokinet Biopharm. 1989; 17(5):551-70.
PMID: 2614685
DOI: 10.1007/BF01071349.
Propranolol in neurosurgical patients with sinus tachycardia. Cardiovascular effects and mode of use.
ZATTONI J, LUCCHELLI P, Siani C, Orzalesi L, Molinino M
Acta Neurochir (Wien). 1978; 43(3-4):281-95.
PMID: 707182
DOI: 10.1007/BF01587963.
Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing.
Stephens J, Hayward R, Ead H, Adams L, Hamer J, Spurrell R
Br Heart J. 1978; 40(8):856-63.
PMID: 687486
PMC: 483499.
DOI: 10.1136/hrt.40.8.856.
Mechanisms of prolongation of pre-ejection period in patients with left ventricular disease.
Chen W, Gibson D
Br Heart J. 1979; 42(3):304-10.
PMID: 41537
PMC: 482152.
DOI: 10.1136/hrt.42.3.304.
